B precursor type acute leukaemia and Clostridium difficile colitis

Summary:

Clostridium difficile colitis is found among people with B precursor type acute leukaemia, especially for people who are female, 60+ old.

The study analyzes which people have Clostridium difficile colitis with B precursor type acute leukaemia. It is created by eHealthMe based on reports of 33 people who have B precursor type acute leukaemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is B precursor type acute leukaemia?

B precursor type acute leukaemia (lymphoid cancer) is found to be associated with 30 drugs and 106 conditions by eHealthMe. Check the latest studies of B precursor type acute leukaemia.

What is Clostridium difficile colitis?

Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection) is found to be associated with 1,042 drugs and 1,782 conditions by eHealthMe. Check the latest studies of Clostridium difficile colitis.

On Jul, 14, 2026

33 people who have B Precursor Type Acute Leukaemia and Clostridium Difficile Colitis are studied.

Would you have Clostridium difficile colitis when you have B precursor type acute leukaemia?

Gender of people who have B Precursor Type Acute Leukaemia and experienced Clostridium Difficile Colitis *:

female: 84.38 %
male: 15.62 %

Age of people who have B Precursor Type Acute Leukaemia and experienced Clostridium Difficile Colitis *:

Common co-existing conditions for these people *:

Urinary Tract Infection Enterococcal: 14 people, 42.42%
Enterococcal Infection: 12 people, 36.36%
Urinary Tract Infection: 9 people, 27.27%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 2 people, 6.06%
Clostridium Colitis (inflammation of colon by clostridium difficile bacteria infection): 1 person, 3.03%

Common drugs taken by these people *:

Common symptoms for these people *:

Hepatic Infarction (particular area of the liver has lost its blood supply and died): 16 people, 48.48%
Aplasia (defective development or congenital absence of an organ or tissue): 15 people, 45.45%
Hepatotoxicity (chemical-driven liver damage): 13 people, 39.39%
Acute Hepatic Failure: 13 people, 39.39%
Febrile Neutropenia (fever with reduced white blood cells): 9 people, 27.27%
Klebsiella Infection: 9 people, 27.27%
High Blood Pressure: 8 people, 24.24%
Pulmonary Oedema (fluid accumulation in the lungs): 8 people, 24.24%
Erythema Multiforme (a type of hypersensitivity reaction): 8 people, 24.24%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 8 people, 24.24%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Clostridium difficile colitis?

- Check whether Clostridium difficile colitis is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Clostridium difficile colitis and B precursor type acute leukaemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.